GAMMA Investing
ABOS icon

GAMMA Investing’s Acumen Pharmaceuticals ABOS Stock Holding History

GAMMA Investing’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.95K Buy
+877
New +$2.27K ﹤0.01% 3959

Other funds holding ABOS

CA
Clune & Associates Chicago, Illinois $654M AUM 13.19% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ABOS Position: Q3 2026 in Review

GAMMA Investing opened a new position in Acumen Pharmaceuticals (ABOS) in Q3 2026: 877 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #3959 among its holdings.

3 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.

  • GAMMA Investing held 877 shares of Acumen Pharmaceuticals worth $1.95K as of Q3 2026.
  • Acumen Pharmaceuticals was a new GAMMA Investing position in Q3 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3959 holding.
  • 3 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.